JENNY LEE: Open Payments
NPI 1669787255 · FRANKLIN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$548 in 31 payments from 15 companies in 2025. Trend: 2023 $575 · 2024 $690 · 2025 $548
Food & beverage: $548
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $129 |
| Axsome Therapeutics, Inc. | 4 | $86 |
| Lilly USA, LLC | 5 | $75 |
| Corium, LLC | 3 | $41 |
| Exact Sciences Corporation | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Abbott Laboratories | 1 | $24 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: Auvelity, MOUNJARO, Ozempic, Azstarys, Rybelsus, REXULTI, FREESTYLE LIBRE 3, Cologuard Collection Kit.
Industry payments across IN — which companies pay providers there.
